Aguilera T. A.,Rafat M.,Castellini L.,Shehade H.,Kariolis M. S.,Hui A. B. Y.,Giaccia A. J. .2016 .Reprogramming the immunological microenvironment through radiation and targeting Axl. Nature Communications, 7(1) : 1-14.
Preda M.,Ilina R.,Potre O.,Potre C.,Mazilu O. .2020 .Survival analysis of patients with inflammatory breast cancer in relation to clinical and histopathological characteristics. Cancer Management and Research, 12447 : 12455.
Ueno N. T.,Fernandez J. R. E.,Cristofanilli M.,Overmoyer B.,Rea D.,Berdichevski F.,Woodward W. A. .2018 .International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. Journal of Cancer, 9(8) : 1437-1447.
Miricescu D.,Totan A.,Stanescu-Spinu I. I.,Badoiu S. C.,Stefani C.,Greabu M. .2020 .PI3K/AKT/mTOR signaling pathway in breast cancer: from molecular landscape to clinical aspects. International Journal of Molecular Sciences, 22(1) : 173.
Wang X.,Semba T.,Phi L. T. H.,Chainitikun S.,Iwase T.,Lim B.,Ueno N. T. .2020 .Targeting signaling pathways in inflammatory breast cancer. Cancers, 12(9) : 2479-2487.
Bonito Di,Cantile M.,Botti M.,G. M. .2019 .Pathological and molecular characteristics of inflammatory breast cancer. Translational Cancer Research, 8(Suppl 5) : 449-456.
Liu Y.,Song Y.,Ye M.,Hu X.,Wang Z. P.,Zhu X. .2019 .The emerging role of WISP proteins in tumorigenesis and cancer therapy. Journal of Translational Medicine, 17 : 1-14.
Morrow R. J.,Etemadi N.,Yeo B.,Ernst M. .2017 .Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer. Mediators of Inflammation, : 4754827-4754827.
Movchan O. V.,Bagmut I. Y.,Sheremet M. I.,Sukhanova L. A.,Kolisnyk I. L.,Bagmut O. V.,Lazaruk O. V. .2023 .Prognostic value of the level of expression of cell wall proteins and cytokines during inflammation in tumor tissue culture in patients with type 2 diabetes mellitus. Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 30(1) : 34-41.
Fernandez S. V.,MacFarlane A. W.,Jillab M.,Arisi M. F.,Yearley J.,Annamalai L.,Campbell K. S. .2020 .Immune phenotype of patients with stage IV metastatic inflammatory breast cancer. Breast Cancer Research, 22(1) : 1-16.
Amrith B. P.,Jain P.,Chaudhari K. A.,Sharma M.,Batra U. .2019 .Severe hypoglycemia with trastuzumab: An unseen adverse event. South Asian Journal of Cancer, 8(03) : 149-149.
Fumagalli C.,Ranghiero A.,Gandini S.,Corso F.,Taormina S.,De Camilli E.,Barberis M. .2020 .Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses. Breast Cancer Research, 22(1) : 1-11.
Gallagher A. .2020 .A 26-Year Study Highlights Invasive Breast Cancer Recurrence After treatment. Oncology Times, 42(20) : 28-35.
Mussbacher M.,Salzmann M.,Brostjan C.,Hoesel B.,Schoergenhofer C.,Datler H.,Schmid J. A. .2019 .Cell Type-Specific Roles of NFκ B Linking Inflammation and Thrombosis. , 10 : 85-85.
Mahmoud M.,Abdel-Rasheed M.,Galal E. R.,El-Awady R. R. .2024 .Factors defining human adipose stem/stromal cell immunomodulation in vitro. Stem Cell Reviews and Reports, 20(1) : 175-205.
Yan S.,Vandewalle N.,De Beule N.,Faict S.,Maes K.,De Bruyne E.,De Veirman K. .2019 .AXL receptor tyrosine kinase as a therapeutic target in hematological malignancies: Focus on multiple myeloma. Cancers, 11(11) : 1727.
Yang P. D.,Peng Q. Q.,Lian W. B.,Fu F. M.,Wang C.,Chen D. .2022 .Validation of the Eighth American Joint Committee on Cancer Anatomic and Prognostic Staging System for Breast Cancer. Journal of Surgical Research, 270 : 539-546.
Zhou Y.,Cui C.,Ma X.,Luo W.,Zheng S. G.,Qiu W.,NF-κ B .2020 .-mediated inflammation in multiple sclerosis. Frontiers in Immunology, 11 : 391-391.
Czauderna C.,Castven D.,Mahn F. L.,Marquardt J. U. .2019 .Context-dependent role of NF-κ B signaling in primary liver cancer-from tumor development to therapeutic implications. Cancers, 11(8) : 1053.
Fliegauf M.,Bryant V. L.,Frede N.,Slade C.,Woon S. T.,Lehnert K.,Grimbacher B. .2015 .Haploinsufficiency of the NF- κ B1 subunit p50 in common variable immunodeficiency. The American Journal of Human Genetics, 97(3) : 389-403.
Lei M. M. L.,Lee T. K. W. .2021 .Cancer stem cells: Emerging key players in immune evasion of cancers. Frontiers in Cell and Developmental Biology, 9 : 692940.
Lee J.,Pearson H.,Iwase T.,Fuson T.,Lalani J.,Ueno A. S.,N. T. A. S. .2021 .PI3K and MAPK pathways as targets for combination with the pan-HER irreversible inhibitor Neratinib in HER2-positive breast cancer and TNBC by kinome RNAi screening. Biomedicines, 9(7) : 740.
Acevedo-Díaz A.,Morales-Cabán B. M.,Zayas-Santiago A.,MartínezMontemayor M. M.,Suárez-Arroyo I. J. .2022 .SCAMP3 Regulates EGFR and Promotes Proliferation and Migration of Triple-Negative Breast Cancer Cells through the Modulation of AKT, ERK, and STAT3 Signaling Pathways. , 14(11) : 2807-2817.
Ruxolitinib W . .. , : .
Hibino S.,Kawazoe T.,Kasahara H.,Itoh S.,Ishimoto T.,SakataYanagimoto M.,Taniguchi K. .2021 .Inflammation-induced tumorigenesis and metastasis. International Journal of Molecular Sciences, 22(11) : 5421.
Hidalgo-Estévez A. M.,Stamatakis K.,Jiménez-Martínez M.,LópezPérez M.,Fresno R.,M. R. .2020 .Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer. , 11 : 533-533.
Quail D. F.,Joyce J. A. .2013 .Microenvironmental regulation of tumor progression and metastasis. Nature Medicine, 19(11) : 1423-1437.
Reyes M. E. .2014 .Targeting Cox-2 And Rank In Aggressive Breast Cancers: Inflammatory Breast Cancer And Triple-Negative Breast Cancer. , : .
Wolfe A. R.,Trenton N. J.,Debeb B. G.,Larson R.,Ruffell B.,Chu K.,Woodward W. A. .2016 .Mesenchymal stem cells and macrophages interact through IL-6 to promote inflammatory breast cancer in pre-clinical models. Oncotarget, 7(50) : 82482-82492.
Shihab I.,Khalil B. A.,Elemam N. M.,Hachim I. Y.,Hachim M. Y.,Hamoudi R. A.,Maghazachi A. A. .2020 .Understanding the role of innate immune cells and identifying genes in breast cancer microenvironment. Cancers, 12(8) : 2226-2235.
Jiao D.,Zhu J.,Guo X.,Yang Y.,Xiao H.,Liu Z. .2021 .Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis. BMC Cancer, 21 : 1-7.
Johnson A. M.,Kleczko E. K.,Nemenoff R. A. .2020 .Eicosanoids in cancer: new roles in immunoregulation. , 11 : 595498.
Heeren A. M.,Rotman J.,Stam A. G. M.,Pocorni N.,Gassama A. A.,Samuels S.,de Gruijl S. .2019 .Efficacy of PD-1 blockade in cervical cancer is related to a CD8+ FoxP3+ CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels. Journal for Immunotherapy of Cancer, 7 : 1-14.
Matsuda N.,Wang X.,Lim B.,Krishnamurthy S.,Alvarez R. H.,Willey J. S.,Ueno N. T. .2018 .Safety and efficacy of panitumumab plus neoadjuvant chemotherapy in patients with primary HER2-negative inflammatory breast cancer. JAMA Oncology, 4(9) : 1207-1213.
Oh D. Y.,Kwek S. S.,Raju S. S.,Li T.,McCarthy E.,Chow E.,Fong L. .2020 .Intratumoral CD4+ T cells mediate anti-tumor cytotoxicity in human bladder cancer. Cell, 181(7) : 1612-1625.
Sheremet M. I.,Yuriivna B. I.,Volodimirovich M. O.,Ivanovich S. I.,Oleksandrovich L. A.,Viktorivna D. I.,Leonidovich K. I. .2022 .Characteristics of certain genetical and biological properties of carcinogenesis in the development of inflammatory breast cancer with type 2 diabetes mellitus and tumor relapse. Romanian Journal of Diabetes Nutrition and Metabolic Diseases, 29(2) : 245-252.
Narod S. A.,Rakovitch E. .2014 .A comparison of the risks of inbreast recurrence after a diagnosis of DCIS or early invasive breast cancer. Current Oncology, 21(3) : 119-124.